Other Stories

Full Video

S. Korean gov't to pay full cost of US $765 treatment with budget for 38,000 doses Updated: 2021-09-14 07:38:29 KST

South Korean health authorities say treating COVID-19 patients is the government's duty by law and it will pay for anti-viral medication at an expected cost of around 765 U.S. dollars a dose.
The treatment is being seen as a game changer with COVID-19 now expected to be around forever.
South Korea is in talks with various manufacturers, and as of now, Merck and Co., Pfizer, and Roche are the pharmaceutical companies in phase 3 of clinical trials.
Merck and Co is leading the race and could even win emergency authorization use from the FDA for its drug as soon as this year.
Health authorities here say they've allocated more than 30 million U.S. dollars for this year and the next enough to secure almost 40-thousand doses.
Reporter : tkim@arirang.com
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.